Cannabis Suisse Corp. (CSUI) EBITDA (2016 - 2026)

Cannabis Suisse (CSUI) has reported EBITDA for 11 consecutive years, with -$68333.0 the latest figure, recorded in Q1 2026.

• On a quarterly basis, EBITDA fell 3.96% year-over-year to -$68333.0 in Q1 2026; TTM through Feb 2026 was -$278742.0, a 10.79% increase from a year earlier, with the FY2025 full-year figure at -$283769.0, down 12.3% from the prior year.
• EBITDA was -$68333.0 for Q1 2026 at Cannabis Suisse, up from -$73919.0 in the prior quarter.
• Over five years, EBITDA peaked at -$22473.0 in Q2 2022 and troughed at -$154991.0 in Q1 2023.
• A 5-year average of -$68451.8 and a median of -$65727.0 in 2025 frame the typical range for EBITDA.
• Across the five-year window, EBITDA soared 96.67% in 2022 and sank 281.93% in 2023, its largest moves.
• Over 5 years, EBITDA stood at -$28314.0 in 2022, then tumbled by 75.32% to -$49641.0 in 2023, then plunged by 83.82% to -$91248.0 in 2024, then rose by 18.99% to -$73919.0 in 2025, then gained by 7.56% to -$68333.0 in 2026.
• The last three EBITDA figures came in at -$68333.0 (Q1 2026), -$73919.0 (Q4 2025), and -$83474.0 (Q3 2025), per Business Quant data.